Security key
92859E207
Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (VVOS)
CUSIP: 92859E207
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 97,799
- Total 13F value
- $45,918
- Share change
- 0
- SEC-reported price per share
- $0.47
- Number of holders
- 4
- Shares outstanding
- 13,985,437
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
4
Top holders
4
VVOS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Vivos Therapeutics, Inc. SEC filings
Vivos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92859E207
Recent filing periods:
Ownership snapshot
Top reported holders of VVOS - Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
V-Co Investors 3 LLC
Disclosed value leader
V-Co Investors 3 LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 20%
13D/G row: V-Co Investors 3 LLC
Showing 1-6 of 15 holder rows.
Quick read
V-Co Investors 3 LLC leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens V-Co Investors 3 LLC's linked filing trail.
Comparable ownership
Top 5
V-Co Investors 3 LLC
20%
V-CO Investors LLC
20%
V-Co Investors 4 LLC
20%
Dawei Luo
8.5%
ARMISTICE CAPITAL, LLC
8.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| V-Co Investors 3 LLC |
3/4/5
13D/G
10%+ Owner · Michael C. Skaff
|
20%
from 13D/G
|
$8,766,191
6,704,371 shares
mixed-class rows
|
+$7,170,000 | 31 Mar 2026 |
| V-CO Investors LLC |
13D/G
SP Manager LLC
|
20%
|
$4,188,594
1,342,498 shares
|
+$2,583,360 | 09 Jun 2025 |
| V-Co Investors 4 LLC |
13D/G
Michael C. Skaff
|
20%
|
$1,363,163
2,783,102 shares
|
$0 | 30 Jun 2026 |
| Dawei Luo |
13D/G
|
8.5%
|
$3,432,096
572,016 shares
|
$0 | 08 Jul 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
8.3%
|
$1,339,031
1,115,859 shares
|
$0 | 31 Mar 2026 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$796,804
297,315 shares
|
$0 | 22 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
97,799
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
23
Q2 2026 holders
4
Holder diff
-19
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend